Tag: Prescription Drugs
Biogen Cuts Price of Controversial Aduhelm in Half
Drug shows promise in clearing brain plaques believed to play a role in Alzheimer disease
ASH: Axicabtagene Ciloleucel Slows Large B-Cell Lymphoma
Event-free survival prolonged with axi-cel versus standard care as second-line therapy for refractory, relapsed disease
First Long-Acting Injectable Approved for HIV PrEP
Apretude, administered every two months, is approved in adults and adolescents at risk for HIV infection
Molnupiravir Cuts Risk for Severe COVID-19 Illness in Adults
Risk for hospitalization or death lower in at-risk adults with mild-to-moderate COVID-19 receiving oral therapy with molnupiravir versus placebo
Opioid Rx Up, Non-Rx Therapy Down During the Pandemic
Nonpharmacologic therapy decreased, opioid prescribing increased for patients seeking treatment for pain management in 2020 versus 2019
Number of Older People With HIV on ART Projected to Increase
Simulation model of people with HIV using ART in the U.S. projects increase in overall median age from 50 years in 2020 to 52 years in 2030
FDA Allows Abortion Pill to Stay Available by Mail
After a telemedicine appointment with a provider, patients can receive medication via the mail
SGLT2 Inhibitor Use May Benefit Patients With HFpEF
SGLT2 inhibitor use may reduce the risk for CV death or hospitalization for heart failure in HF patients with preserved ejection fraction
Some U.S. Adults With Hypertension Using Meds That May Raise BP
Overall, 15 percent of U.S. adults report using medications that may raise blood pressure, including 18.5 percent of adults with hypertension
Pfizer Says Final Data Show COVID-19 Pill Stays Strong Against Severe Illness
Latest results show that drug cuts hospitalizations, deaths by nearly 90 percent when taken within three to five days of the start of symptoms
